1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    
























































































































    Quantitative Analysis of the Olfactory System in COVID-19: An MR Imaging Study | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleHead & Neck

  
      
Open Access

  
      
Quantitative Analysis of the Olfactory System in COVID-19: An MR Imaging Study
  
    	
E. Altunisik, A.H. Baykan, S. Sahin, E. Aydin and S.M. Erturk

  
    	
American Journal of Neuroradiology December 2021,  42 (12) 2207-2214; DOI: https://doi.org/10.3174/ajnr.A7278 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵
    1. Brann  DH, 
    2. Tsukahara  T, 
    3. Weinreb  C, et al
    . Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv 2020;6:eabc5801 doi:10.1126/sciadv.abc5801 pmid:32937591
    FREE Full Text
  2. 2.↵
    1. Li  YC, 
    2. Bai  WZ, 
    3. Hirano  N, et al
    . Coronavirus infection of rat dorsal root ganglia: ultrastructural characterization of viral replication, transfer and the early response of satellite cells. Virus Res 2012;163:628–35 doi:10.1016/j.virusres.2011.12.021 pmid:22248641
    CrossRefPubMed
  3. 3.↵
    1. Baig  AM, 
    2. Khaleeq  A, 
    3. Ali  U, et al
    . Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020;11:995–98 doi:10.1021/acschemneuro.0c00122 pmid:32167747
    CrossRefPubMed
  4. 4.↵
    1. Li  YC, 
    2. Bai  WZ, 
    3. Hashikawa  T
    . The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 2020;92:552–55 doi:10.1002/jmv.25728 pmid:32104915
    CrossRefPubMed
  5. 5.↵
    1. Aggarwal  G, 
    2. Lippi  G, 
    3. Henry  BM
    . Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke 2020;15:385–89 doi:10.1177/1747493020921664 pmid:32310015
    CrossRefPubMed
  6. 6.↵
    1. Parauda  SC, 
    2. Gao  V, 
    3. Gewirtz  AN, et al
    . Posterior reversible encephalopathy syndrome in patients with COVID-19. J Neurol Sci 2020;416:117019 doi:10.1016/j.jns.2020.117019 pmid:32679347
    CrossRefPubMed
  7. 7.↵
    1. Mao  L, 
    2. Jin  H, 
    3. Wang  M, et al
    . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683–90 doi:10.1001/jamaneurol.2020.1127 pmid:32275288
    CrossRefPubMed
  8. 8.↵
    1. Altunisik  E, 
    2. Sayiner  HS, 
    3. Aksoz  S, et al
    . Neurological symptoms in COVID-19 patients. Bratisl Lek Listy 2021;122:39–44 doi:10.4149/BLL_2021_004 pmid:33393319
    CrossRefPubMed
  9. 9.↵
    1. Sedaghat  AR, 
    2. Gengler  I, 
    3. Speth  MM
    . Olfactory dysfunction: a highly prevalent symptom of COVID-19 with public health significance. Otolaryngol Head Neck Surg 2020;163:12–15 doi:10.1177/0194599820926464 pmid:32366160
    CrossRefPubMed
  10. 10.↵
    1. Lechien  JR, 
    2. Chiesa-Estomba  CM, 
    3. De Siati  DR, et al
    . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19); a multicenter European study. Eur Arch Otorhinolaryngol 2020;277:2251–61 doi:10.1007/s00405-020-05965-1 pmid:32253535
    CrossRefPubMed
  11. 11.↵
    1. Klopfenstein  T, 
    2. Kadiane-Oussou  NJ, 
    3. Toko  L, et al
    . Features of anosmia in COVID-19. Med Mal Infect 2020;50:436–39 doi:10.1016/j.medmal.2020.04.006 pmid:32305563
    CrossRefPubMed
  12. 12.↵
    1. Wölfel  R, 
    2. Corman  VM, 
    3. Guggemos  W, et al
    . Virological assessment of hospitalized patients with COVID-2019. Nature 2020;581:465–69 doi:10.1038/s41586-020-2196-x pmid:32235945
    CrossRefPubMed
  13. 13.↵
    1. Jafek  BW, 
    2. Murrow  B, 
    3. Michaels  R, et al
    . Biopsies of human olfactory epithelium. Chem Senses 2002;27:623–28 doi:10.1093/chemse/27.7.623 pmid:12200342
    CrossRefPubMedWeb of Science
  14. 14.↵
    1. Cömert  A, 
    2. Kahiloğulları  G, 
    3. Cömert  E, et al
    . Bulbus Olfactorius, Tractus Olfactorius, Sulcus Olfactorius ve Trigonum Olfactorium Morfometrisi: Anatomik Çalışma. Ankara Üniversitesi Tıp Fakültesi Mecmuası 2009;62:149–52
  15. 15.↵
    1. Yousem  DM, 
    2. Geckle  RJ, 
    3. Bilker  WB, 
    4. Doty  RL
    . Olfactory bulb and tract and temporal lobe volumes. Normative data across decades. Ann N Y Acad Sci 1998;855:546–55 doi:10.1111/j.1749-6632.1998.tb10624.x pmid:9929650
    CrossRefPubMedWeb of Science
  16. 16.↵
    1. Altunisik  E, 
    2. Baykan  AH
    . Comparison of the olfactory bulb volume and the olfactory tract length between patients diagnosed with essential tremor and healthy controls: findings in favor of neurodegeneration. Cureus 2019;11:e5846 doi:10.7759/cureus.5846 pmid:31754581
    CrossRefPubMed
  17. 17.↵
    1. Altunisik  E, 
    2. Baykan  AH
    . Decreased olfactory bulb volume in patients with restless legs syndrome. Anatolian Journal of Psychiatry 2020;21:537–43
  18. 18.↵
    1. Cullu  N, 
    2. Yeniçeri  IO, 
    3. Guney  B, et al
    . Evaluation of olfactory bulbus volume and olfactory sulcus depth by 3 T MR. Surg Radiol Anat 2020;42:1113–18 doi:10.1007/s00276-020-02484-w pmid:32377954
    CrossRefPubMed
  19. 19.↵
    1. Hummel  T, 
    2. Witt  M, 
    3. Reichmann  H, et al
    . Immunohistochemical, volumetric, and functional neuroimaging studies in patients with idiopathic Parkinson’s disease. J Neurol Sci 2010;289:119–22 doi:10.1016/j.jns.2009.08.026 pmid:19775703
    CrossRefPubMed
  20. 20.↵
    1. Sahin  S, 
    2. Baykan  AH, 
    3. Altunisik  E, et al
    . Quantitative analysis of healthy olfactory sulcus depth, olfactory tract length and olfactory bulb volume in the pediatric population: a magnetic resonance study. Folia Morphol (Warsz) 2021;80:33–39 doi:10.5603/FM.a2020.0125 pmid:33084007
    CrossRefPubMed
  21. 21.↵
    1. Rombaux  P, 
    2. Duprez  T, 
    3. Hummel  T
    . Olfactory bulb volume in the clinical assessment of olfactory dysfunction. Rhinology 2009;47:3–9 pmid:19382487
    PubMedWeb of Science
  22. 22.↵
    1. Duprez  TP, 
    2. Rombaux  P
    . Imaging the olfactory tract (cranial nerve 1). Eur J Radiol 2010;74:288–98 doi:10.1016/j.ejrad.2009.05.065 pmid:20303227
    CrossRefPubMed
  23. 23.↵
    1. Schneider  JF, 
    2. Floemer  F
    . Maturation of the olfactory bulbs: MR imaging findings. AJNR Am J Neuroradiol 2009;30:1149–52 doi:10.3174/ajnr.A1501 pmid:19279285
    Abstract/FREE Full Text
  24. 24.↵
    1. Chen  S, 
    2. Tan  Hy, 
    3. Wu  Zh, et al
    . Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson’s disease and multiple system atrophy. Eur J Radiol 2014;83:564–70 doi:10.1016/j.ejrad.2013.11.024 pmid:24360232
    CrossRefPubMed
  25. 25.↵
    1. Welge-Lussen  A, 
    2. Wolfensberger  M
    . Olfactory disorders following upper respiratory tract infections. Adv Otorhinolaryngol 2006;63:125–32 doi:10.1159/000093758 pmid:16733337
    CrossRefPubMed
  26. 26.↵
    1. Jalessi  M, 
    2. Barati  M, 
    3. Rohani  M, et al
    . Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19. Neurol Sci 2020;41:2331–38 doi:10.1007/s10072-020-04590-4 pmid:32656713
    CrossRefPubMed
  27. 27.↵
    1. Cooper  KW, 
    2. Brann  DH, 
    3. Farruggia  MC, et al
    . COVID-19 and the chemical senses: supporting players take center stage. Neuron 2020;107:219–33 doi:10.1016/j.neuron.2020.06.032 pmid:32640192
    CrossRefPubMed
  28. 28.↵
    1. Twomey  JA, 
    2. Barker  CM, 
    3. Robinson  G, et al
    . Olfactory mucosa in herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 1979;42:983–87 doi:10.1136/jnnp.42.11.983 pmid:228010
    Abstract/FREE Full Text
  29. 29.↵
    1. Chiu  A, 
    2. Fischbein  N, 
    3. Wintermark  M, et al
    . COVID-19-induced anosmia associated with olfactory bulb atrophy. Neuroradiology 2021;63:147–48 doi:10.1007/s00234-020-02554-1 pmid:32930820
    CrossRefPubMed
  30. 30.↵
    1. Laurendon  T, 
    2. Radulesco  T, 
    3. Mugnier  J, et al
    . Bilateral transient olfactory bulb edema during COVID-19–related anosmia. Neurology 2020;95:224–25 doi:10.1212/WNL.0000000000009850 pmid:32444492
    Abstract/FREE Full Text
  31. 31.↵
    1. Tsivgoulis  G, 
    2. Fragkou  PC, 
    3. Lachanis  S, et al
    . Olfactory bulb and mucosa abnormalities in persistent COVID-19 induced anosmia: a magnetic resonance imaging study. Eur J Neurol 2021;1:6–8 doi:10.1111/ene.14537 pmid:32939911
    CrossRefPubMed
  32. 32.↵
    1. Li  CW, 
    2. Syue  LS, 
    3. Tsai  YS, et al
    . Anosmia and olfactory tract neuropathy in a case of COVID-19. J Microbiol Immun Infect 2021;54:93–96 doi:10.1016/j.jmii.2020.05.017 pmid:32576457
    CrossRefPubMed
  33. 33.↵
    1. Chetrit  A, 
    2. Lechien  JR, 
    3. Ammar  A, et al
    . Magnetic resonance imaging of COVID-19 anosmic patients reveals abnormalities of the olfactory bulb: preliminary prospective study. J Infect 2020;81:816–46 doi:10.1016/j.jinf.2020.07.028 pmid:32739489
    CrossRefPubMed
  34. 34.↵
    1. Aragão  MF, 
    2. Leal  MC, 
    3. Filho  OC, et al
    . Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on MRI. AJNR Am J Neuroradiol 2020;41:1703–06 doi:10.3174/ajnr.A6675 pmid:32586960
    Abstract/FREE Full Text
  35. 35.↵
    1. Politi  LS, 
    2. Salsano  E, 
    3. Grimaldi  M
    . Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol 2020;77:1028–29 doi:10.1001/jamaneurol.2020.2125 pmid:32469400
    CrossRefPubMed
  36. 36.↵
    1. Karimi-Galougahi  M, 
    2. Yousefi-Koma  A, 
    3. Bakhshayeshkaram  M, et al
    . 18FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19. Acad Radiol 2020;27:1042–43 doi:10.1016/j.acra.2020.04.030 pmid:32386948
    CrossRefPubMed
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Quantitative Analysis of the Olfactory System in COVID-19: An MR Imaging Study
  
    	
E. Altunisik, A.H. Baykan, S. Sahin, E. Aydin, S.M. Erturk

  
    	
 American Journal of Neuroradiology Dec 2021, 42 (12) 2207-2214; DOI: 10.3174/ajnr.A7278 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement